AAV9-Follistatin
compound
AAV9-Follistatin is a gene therapy approach that uses an adeno-associated virus (AAV9) vector to deliver the follistatin gene. Follistatin is a protein that inhibits myostatin, a negative regulator of muscle growth, potentially enhancing muscle mass and strength. This therapy is significant for longevity and health optimization as it may help counteract age-related muscle loss and improve overall physical function.
Updated 8/11/2026
AAV9-Follistatin Gene Therapy
compound
AAV9-Follistatin gene therapy involves using an adeno-associated virus (AAV9) vector to deliver the follistatin gene into cells. Follistatin is a protein that inhibits myostatin, a growth factor that limits muscle growth. This therapy aims to enhance muscle mass and strength, which could be beneficial for age-related muscle loss and other muscle-wasting conditions, contributing to improved longevity and healthspan.
Updated 8/5/2026